Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 39, Pages 24251-24257
Publisher
Proceedings of the National Academy of Sciences
Online
2020-09-15
DOI
10.1073/pnas.2006684117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
- (2020) Thomas C. T. Michaels et al. Nature Chemistry
- A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
- (2019) Francesco Panza et al. Nature Reviews Neurology
- Mechanism of amyloid protein aggregation and the role of inhibitors
- (2019) Sara Linse PURE AND APPLIED CHEMISTRY
- Chemical Kinetics for Bridging Molecular Mechanisms and Macroscopic Measurements of Amyloid Fibril Formation
- (2018) Thomas C.T. Michaels et al. Annual Review of Physical Chemistry
- Secondary nucleation in amyloid formation
- (2018) Mattias Törnquist et al. CHEMICAL COMMUNICATIONS
- Reaction rate theory for supramolecular kinetics: application to protein aggregation
- (2018) Thomas C. T. Michaels et al. MOLECULAR PHYSICS
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms
- (2018) Sofia Giorgetti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Cleveland Clinic Lou Ruvo Center for Brain Health: Keeping Memory Alive
- (2018) Jeffrey Cummings et al. JOURNAL OF ALZHEIMERS DISEASE
- Impact of nanoparticles on amyloid peptide and protein aggregation: a review with a focus on gold nanoparticles
- (2018) Torsten John et al. Nanoscale
- SAR by kinetics for drug discovery in protein misfolding diseases
- (2018) Sean Chia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity
- (2017) Michele Perni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
- (2017) Giuliana Fusco et al. SCIENCE
- The Amyloid Phenomenon and Its Links with Human Disease
- (2017) Christopher M. Dobson Cold Spring Harbor Perspectives in Biology
- Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method
- (2017) Francesco A. Aprile et al. Science Advances
- The Quest for Small Molecules as Amyloid Inhibiting Therapies for Alzheimer's Disease
- (2017) Hozefa Amijee et al. JOURNAL OF ALZHEIMERS DISEASE
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Kinetics of spontaneous filament nucleation via oligomers: Insights from theory and simulation
- (2016) Anđela Šarić et al. JOURNAL OF CHEMICAL PHYSICS
- Physical determinants of the self-replication of protein fibrils
- (2016) Anđela Šarić et al. Nature Physics
- Molecular mechanisms of protein aggregation from global fitting of kinetic models
- (2016) Georg Meisl et al. Nature Protocols
- Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease
- (2016) Johnny Habchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation
- (2016) Paolo Arosio et al. Nature Communications
- An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic A 42 aggregates linked with Alzheimers disease
- (2016) J. Habchi et al. Science Advances
- Kinetic theory of protein filament growth: Self-consistent methods and perturbative techniques
- (2015) Thomas C. T. Michaels et al. INTERNATIONAL JOURNAL OF MODERN PHYSICS B
- Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation
- (2015) Céline Galvagnion et al. Nature Chemical Biology
- A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
- (2015) Samuel I A Cohen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins
- (2015) Pietro Sormanni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
- (2015) Samuel I A Cohen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
- (2014) Eric Karran et al. ANNALS OF NEUROLOGY
- Role of Cosolutes in the Aggregation Kinetics of Monoclonal Antibodies
- (2014) Lucrèce Nicoud et al. JOURNAL OF PHYSICAL CHEMISTRY B
- The amyloid state and its association with protein misfolding diseases
- (2014) Tuomas P. J. Knowles et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Crucial role of nonspecific interactions in amyloid nucleation
- (2014) Anđela Šarić et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemical kinetics for drug discovery to combat protein aggregation diseases
- (2014) Paolo Arosio et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A new roadmap for drug development for Alzheimer's disease
- (2013) Robert E. Becker et al. NATURE REVIEWS DRUG DISCOVERY
- Proliferation of amyloid- 42 aggregates occurs through a secondary nucleation mechanism
- (2013) S. I. A. Cohen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alzheimer Mechanisms and Therapeutic Strategies
- (2012) Yadong Huang et al. CELL
- The Amyloid State of Proteins in Human Diseases
- (2012) David Eisenberg et al. CELL
- Inhibition of Amyloid Formation
- (2012) Torleif Härd et al. JOURNAL OF MOLECULAR BIOLOGY
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- The many faces of α-synuclein: from structure and toxicity to therapeutic target
- (2012) Hilal A. Lashuel et al. NATURE REVIEWS NEUROSCIENCE
- Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease
- (2011) Qin Nie et al. ACTA PHARMACOLOGICA SINICA
- Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments
- (2011) Samuel I. A. Cohen et al. JOURNAL OF CHEMICAL PHYSICS
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- A causative link between the structure of aberrant protein oligomers and their toxicity
- (2010) Silvia Campioni et al. Nature Chemical Biology
- Protein aggregation diseases: pathogenicity and therapeutic perspectives
- (2010) Adriano Aguzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Development of Tau Aggregation Inhibitors for Alzheimer's Disease
- (2009) Bruno Bulic et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- An Analytical Solution to the Kinetics of Breakable Filament Assembly
- (2009) T. P. J. Knowles et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now